Korean J Urol.  2012 Apr;53(4):285-287.

Surgical Treatment of Inferior Vena Cava Invasion in Patients with Renal Pelvis Transitional Cell Carcinoma by Use of Human Cadaveric Aorta

• Nam JK
• Moon KM
• Park SW
• Chung MK

Abstract

We herein report a case of radical nephroureterectomy and replacement of the inferior vena cava (IVC) with ahuman cadaveric aortic graft for a patient with renal pelvis transitional cell carcinoma associated with IVC infiltration. In advanced disease, radical surgery is essential to achieve long-term survival. This case entails the use of another treatment option among the numerous options currently available for the management of patients with advanced renal cancer associated with IVC invasion.

Keyword

Inferior vena cava; Kidney pelvis; Vascular grafting

MeSH Terms

Aorta
Cadaver
Carcinoma, Transitional Cell
Humans
Kidney Neoplasms
Kidney Pelvis
Transplants
Vascular Grafting
Vena Cava, Inferior

Figure

• 

  FIG. 1 (A) Vertical and (B) axial computed tomography images showing a large (8 cm × 6.5 cm) irregular mass. (C) The 9-month follow-up image of the patient confirmed no recurrence and a patent cadaveric aorticgraft.

• 

  FIG. 2 Intraoperative findings after caval replacement with a cadaveric aortic graft.

• 

  FIG. 3 Microscopic findings showing tumor cells infiltrating the inferior vena cava wall (H&E, ×100).

Reference

1. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998. 52:594–601.

2. Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol. 2003. 47:155–169.

3. Fujimoto M, Tsujimoto Y, Nonomura N, Kojima Y, Miki T, Ariyoshi H, et al. Renal pelvic cancer with tumor thrombus in the vena cava inferior. A case report and review of the literature. Urol Int. 1997. 59:263–265.

4. Al Otaibi M, Abou Youssif T, Alkhaldi A, Sircar K, Kassouf W, Aprikian A, et al. Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome. BJU Int. 2009. 104:1467–1470.

5. Bower TC, Nagorney DM, Cherry KJ Jr, Toomey BJ, Hallett JW, Panneton JM, et al. Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg. 2000. 31:270–281.

6. Hardwigsen J, Baqué P, Crespy B, Moutardier V, Delpero JR, Le Treut YP. Resection of the inferior vena cava for neoplasms with or without prosthetic replacement: a 14-patient series. Ann Surg. 2001. 233:242–249.

7. Montie JE, el Ammar R, Pontes JE, Medendorp SV, Novick AC, Streem SB, et al. Renal cell carcinoma with inferior vena cava tumor thrombi. Surg Gynecol Obstet. 1991. 173:107–115.

8. Caldarelli G, Minervini A, Guerra M, Bonari G, Caldarelli C, Minervini R. Prosthetic replacement of the inferior vena cava and the iliofemoral vein for urologically related malignancies. BJU Int. 2002. 90:368–374.

9. Jibiki M, Iwai T, Inoue Y, Sugano N, Kihara K, Hyochi N, et al. Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava. J Vasc Surg. 2004. 39:829–835.

10. Bissada NK, Yakout HH, Babanouri A, Elsalamony T, Fahmy W, Gunham M, et al. Long-term experience with management of renal cell carcinoma involving the inferior vena cava. Urology. 2003. 61:89–92.